Peripheral blood lymphocyte subset shifts in patients with untreated hematological tumors: evidence for systemic activation of the T cell compartment.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis

• Publication date

  1998-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0145-2126(97)00152-5PMID 9593474
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Lysis of autologous tumor cells by blood lymphocytes tested at the time of surgery

  2004cited by this paper
• Clonal expansion within the CD4+CD57+ and CD8+CD57+ T cell subsets in chronic lymphocytic leukemia.

  1997cited by this paper
• Multivariate reconstruction of lymphocyte profiles in a two-dimensional graphical model as a tool for the investigation of lymphocyte subset distribution in health and disease.

  1997cited by this paper
• The enigma of CD57+CD28– T cell expansion—anergy or activation?

  1996cited by this paper
• Circulating Ki67 positive lymphocytes in multiple myeloma and benign monoclonal gammopathy.

  1995cited by this paper
• CD8+ T cell subsets in aging.

  1995cited by this paper
• A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group.

  1994cited by this paper
• T cell repertoire in patients with B chronic lymphocytic leukemia. Evidence for multiple in vivo T cell clonal expansions.

  1994cited by this paper
• Anti-tumor antibody produced by human tumor-infiltrating and peripheral blood B lymphocytes

  1994cited by this paper
• Stimulatory effects of immune reactions upon the growths of untransplanted tumors.

  1994cited by this paper
• Tumor immunotherapy: the tumor cell as an antigen-presenting cell.

  1994cited by this paper
• CD28- T lymphocytes. Antigenic and functional properties.

  1993cited by this paper
• CD28 ligation by monoclonal antibodies or B7/BB1 provides an accessory signal for the cyclosporin A-resistant generation of cytotoxic T cell activity.

  1993cited by this paper
• Lymphocyte subsets and natural killer cell activity in healthy old people and centenarians.

  1993cited by this paper
• Selectively down-regulated expression of major histocompatibility complex class I alleles in human solid tumors.

  1993cited by this paper
• Toward a genetic analysis of tumor rejection antigens.

  1992cited by this paper
• Tumor antigens.

  1992cited by this paper
• Induction of syngeneic cytotoxic T lymphocytes against a B cell tumor. I. Role of idiotypic immunoglobulin.

  1992cited by this paper
• Cancer immunotherapy: are the results discouraging? Can they be improved?

  1992cited by this paper
• Activated T-cell subsets in benign lymphoid hyperplasias and B-cell non-Hodgkin's lymphomas.

  1991cited by this paper
• Lymphocyte subset reference ranges in adult Caucasians.

  1991cited by this paper
• Predominant T cell receptor V gene usage in patients with abnormal clones of B cells.

  1991cited by this paper
• Human Monoclonal Antibodies Reactive with Cell Surface Antigens on Human Leukemia Cell Lines: Many Antibodies Are (Auto)antibodies

  1990cited by this paper
• Activated idiotype-reactive cells in suppressor/cytotoxic subpopulations of monoclonal gammopathies: correlation with diagnosis and disease status.

  1988cited by this paper
• Leu-8 antigen expression is diminished during cell activation but does not correlate with effector function of activated T lymphocytes.

  1988cited by this paper
• Induction of nonspecific cytotoxicity by monoclonal anti-T3 antibodies.

  1985cited by this paper
• Ia determinants on stimulated human T lymphocytes. Occurrence on mitogen- and antigen-activated T cells

  1979cited by this paper
• A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival

  1975cited by this paper

• Immunotherapy in Chronic Lymphocytic Leukemia.

  2025cites this paper
• Systematic review and quantitative meta-analysis of age-dependent human T-lymphocyte homeostasis

  2025cites this paper
• Characterisation of Cytotoxicity-Related Receptors on γδ T Cells in Chronic Lymphocytic Leukaemia

  2025cites this paper
• NK and T-lymphocyte Kinetics Predict Outcome in Myeloma Patients Treated With Elotuzumab, Lenalidomide Plus Dexamethasone.

  2024cites this paper
• The complexities of T-cell dysfunction in chronic lymphocytic leukemia.

  2024cites this paper
• Advancing CAR T-cell therapy for chronic lymphocytic leukemia: exploring resistance mechanisms and the innovative strategies to overcome them

  2024cites this paper
• Posttransplant complications: molecular mechanisms and therapeutic interventions

  2024cites this paper
• Overview on Immunopathology of Chronic Lymphocytic Leukemia and Tumor-Associated Antigens with Therapeutic Applications

  2024cites this paper
• Transforming CLL management with immunotherapy: Investigating the potential of CAR T-cells and bispecific antibodies.

  2024cites this paper
• Natural Killer Cells and Cytotoxic T Cells: Complementary Partners against Microorganisms and Cancer

  2024cites this paper
• MYC-driven synthesis of Siglec ligands is a glycoimmune checkpoint

  2023cites this paper
• PLP2 Could Be a Prognostic Biomarker and Potential Treatment Target in Glioblastoma Multiforme

  2023cites this paper
• Multi-omic analysis of the tumor microenvironment shows clinical correlations in Ph1 study of atezolizumab +/- SoC in MM

  2023cites this paper
• Vaccines in Breast Cancer: Challenges and Breakthroughs

  2023cites this paper
• Immune restoration with ibrutinib plus venetoclax in first-line chronic lymphocytic leukemia: the phase 2 CAPTIVATE study

  2023cites this paper
• Aberrant expression of T cell activation markers and upregulation of Tregs in bone marrow and peripheral blood in acute myeloid leukemia patients

  2023cites this paper
• Preliminary analysis of double‐negative T, double‐positive T, and natural killer T‐like cells in B‐cell chronic lymphocytic leukemia

  2023cites this paper
• High Dimensional Immune Profiling of Smoldering Multiple Myeloma Distinguishes Distinct Tumor Microenvironments.

  2022cites this paper
• Blasts in context: the impact of the immune environment on acute myeloid leukemia prognosis and treatment.

  2022cites this paper
• Impact of Immune Parameters and Immune Dysfunctions on the Prognosis of Patients with Chronic Lymphocytic Leukemia

  2021cites this paper
• Differences in the immune response of the non-metastatic axillary lymph nodes between triple-negative and luminal A breast cancer surrogate subtypes.

  2020cites this paper
• Immune Dysfunctions and Immune-Based Therapeutic Interventions in Chronic Lymphocytic Leukemia

  2020cites this paper
• Dendritic Cell-Regulated T Cell Immunity and Tolerance against Acute Myeloid Leukemia

  2020cites this paper
• PD1 expression on bone marrow T‐cells in newly diagnosed Egyptian AML patients: Correlation with hematological parameters, aberrant antigens expression, and response to induction therapy

  2020cites this paper
• MED15, transforming growth factor beta 1 (TGF-β1), FcγRIII (CD16), and HNK-1 (CD57) are prognostic biomarkers of oral squamous cell carcinoma

  2020cites this paper
• Dissecting the Prognostic Significance and Functional Role of Progranulin in Chronic Lymphocytic Leukemia

  2019cites this paper
• Multiparametric analysis of CD8+ T cell compartment phenotype in chronic lymphocytic leukemia reveals a signature associated with progression toward therapy

  2019cites this paper
• Checkpoint inhibition in the bone marrow

  2018cites this paper
• PI3K p110&dgr; inactivation antagonizes chronic lymphocytic leukemia and reverses T cell immune suppression

  2018cites this paper
• The emerging role of immune checkpoint based approaches in AML and MDS

  2018cites this paper
• Host-related immunodeficiency in the development of multiple myeloma

  2018cites this paper
• Hypomethylating agents in combination with immune checkpoint inhibitors in acute myeloid leukemia and myelodysplastic syndromes

  2018cites this paper
• Targeting the Immune Microenvironment in Acute Myeloid Leukemia: A Focus on T Cell Immunity

  2018cites this paper
• Higher PD-1 expression concurrent with exhausted CD8+ T cells in patients with de novo acute myeloid leukemia.

  2017cites this paper
• Flow Cytometry of T cells and T-cell Neoplasms.

  2017cites this paper
• Immune therapies in acute myeloid leukemia: a focus on monoclonal antibodies and immune checkpoint inhibitors

  2017cites this paper
• The impact of cytomegalovirus infection on natural killer cell responses to vaccines

  2016influential citation
• CD57 in human natural killer cells and T-lymphocytes

  2016cites this paper
• T-Cell Immunoglobulin and ITIM Domain (TIGIT) Associates with CD8+ T-Cell Exhaustion and Poor Clinical Outcome in AML Patients

  2016cites this paper
• Regulation of NKG2D+CD8+ T-cell-mediated antitumor immune surveillance: Identification of a novel CD28 activation-mediated, STAT3 phosphorylation-dependent mechanism

  2016cites this paper
• SUPPRESSION OF ANTI-TUMOR IMMUNITY IN CHRONIC LYMPHOCYTIC LEUKEMIA VIA INTERLEUKIN-10 PRODUCTION

  2016cites this paper
• Suppression of Glut1 and Glucose Metabolism by Decreased Akt/mTORC1 Signaling Drives T Cell Impairment in B Cell Leukemia

  2016cites this paper
• T cells are functionally not impaired in AML: increased PD-1 expression is only seen at time of relapse and correlates with a shift towards the memory T cell compartment

  2015cites this paper
• IMMUNE CELL POPULATIONS AND THEIR PHENOTYPES IN B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA

  2014cites this paper
• The passive-aggressive relationship between CLL-B cells and T cell immunity.

  2014cites this paper
• WORK EXPERIENCE August 1994 – Present Staff member , Specialist in internal Medicine , special competence in Clinical

  2014cites this paper
• Immunomodulation and immune reconstitution in chronic lymphocytic leukemia.

  2014cites this paper
• lymphocytic leukemia Expansion of CMV-specific CD8+CD45RA+CD27- T cells in B-cell chronic

  2013cites this paper
• Functional Significance of CD57 Expression on Human NK Cells and Relevance to Disease

  2013cites this paper
• Understanding the immunodeficiency in chronic lymphocytic leukemia: potential clinical implications.

  2013cites this paper
• Reactive and Non‐neoplastic Phenomena

  2013cites this paper
• T cells from CLL patients exhibit features of T-cell exhaustion but retain capacity for cytokine production.

  2013cites this paper
• Biological therapy and the immune system in patients with chronic myeloid leukemia

  2012cites this paper
• Immune dysfunction in chronic lymphocytic leukemia: the role for immunotherapy.

  2012cites this paper
• MicroRNA-181a – a tale of discrepancies

  2012cites this paper
• Chronic lymphocytic leukemia specific T-cell subset alterations are clone-size dependent and not present in monoclonal B lymphocytosis

  2012cites this paper
• Immune Reconstitution in Chronic Lymphocytic Leukemia

  2012cites this paper
• Expansion of effector T cells associated with decreased PD-1 expression in patients with indolent B cell lymphomas and chronic lymphocytic leukemia

  2012cites this paper
• Human Cancer Biology Expansion of a CD 8 þ PD-1 þ Replicative Senescence Phenotype in Early Stage CLL Patients Is Associated with Inverted CD 4 : CD 8 Ratios and Disease Progression

  2012cites this paper
• UvA-DARE ( Digital Academic Repository ) Targets for the treatment of drug resistant chronic lymphocytic leukemia

  2011cites this paper
• Viruses and Cancer

  2011cites this paper
• Expansion of a CD8+PD-1+ Replicative Senescence Phenotype in Early Stage CLL Patients Is Associated with Inverted CD4:CD8 Ratios and Disease Progression

  2011cites this paper
• Expansion of a CD 8 þ PD-1 þ Replicative Senescence Phenotype in Early Stage CLL Patients Is Associated with Inverted CD 4 : CD 8 Ratios and Disease Progression

  2011cites this paper
• CD57+ T lymphocytes and functional immune deficiency

  2010cites this paper
• Defining novel targets for immunotheraphy of human cancer

  2010cites this paper
• Immunoprofiling of patients with chronic myeloid leukemia at diagnosis and during tyrosine kinase inhibitor therapy

  2010cites this paper
• Activated lymphocytes and monocytes in myelodysplastic syndromes

  2008cites this paper
• T Cells in Patients with B-cell Chronic Lymphocytic Leukemia (B-CLL) and Multiple Myeloma (MM) An Immunological Study

  2007cites this paper
• Immune reconstitution after autologous hematopoietic stem cell transplantation

  2007cites this paper
• UvA-DARE ( Digital Academic Repository ) Antigen receptor triggering and apotopic pathways in neoplastic B cells

  2007cites this paper
• Expression of CD95 on peripheral blood lymphocytes in patients with autoimmune diseases and neoplasms

  2007cites this paper
• Erythropoietin treatment in advanced multiple myeloma is associated with improved immunological functions: could it be beneficial in early disease?

  2006cites this paper
• Increased expression of CD152 (CTLA-4) by normal T lymphocytes in untreated patients with B-cell chronic lymphocytic leukemia

  2005cites this paper
• Clinical and Laboratory Investigations The circulating lymphocyte profiles in patients with discoid lupus erythematosus and systemic lupus erythematosus suggest a pathogenetic relationship

  2004cites this paper
• The circulating lymphocyte profiles in patients with discoid lupus erythematosus and systemic lupus erythematosus suggest a pathogenetic relationship.

  2004cites this paper
• Expression of Surface Lymphocyte Markers in Various Courses of Gastrointestinal Tumors

  2004cites this paper
• Alterations of the expression of T-cell-related costimulatory CD28 and downregulatory CD152 (CTLA-4) molecules in patients with B-cell chronic lymphocytic leukaemia

  2004cites this paper
• Expansion of CMV-specific CD8+CD45RA+CD27- T cells in B-cell chronic lymphocytic leukemia.

  2003cites this paper
• Blood leukocyte subsets and cytokine profile after autologous peripheral blood stem cell transplantation

  2003cites this paper
• Clonal Cytotoxic T Cells in Myeloma

  2003cites this paper
• Different circulating lymphocyte profiles in patients with different subtypes of juvenile idiopathic arthritis.

  2002cites this paper
• CD8+CD28– T cells: Certainties and uncertainties of a prevalent human T‐cell subset

  2002cites this paper
• Comparative immunophenotypic study of lichen sclerosus: epidermotropic CD57+ lymphocytes are numerous--implications for pathogenesis.

  2000cites this paper
• Identifying the Target Cell in Primary Simian Immunodeficiency Virus (SIV) Infection: Highly Activated Memory CD4+ T Cells Are Rapidly Eliminated in Early SIV Infection In Vivo

  2000cites this paper
• Activation of the immune system in cancer patients.

  2000cites this paper
• Expression of CD95 on peripheral blood lymphocytes in patients with autoimmune diseases and neoplasms

  2000cites this paper
• CD57+/CD28− T cells in untreated hemato-oncological patients are expanded and display a Th1-type cytokine secretion profile, ex vivo cytolytic activity and enhanced tendency to apoptosis

  1998cites this paper